NOXXON Pharma
NOXXON Pharma is a Healthcare & Life Sciences startup based in Germany, most recent round Series C+, 3 tracked investors.
About NOXXON Pharma
NOXXON Pharma is a startup founded in 2010 based in Germany. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
NOXXON Pharma is a clinical-stage biotechnology company developing therapies that modulate the tumor microenvironment by targeting the chemokine CXCL12/SDF-1. Its lead program, olaptesed pegol (NOX‑A12), is an L‑RNA aptamer designed to enhance anti-tumor immune responses and improve the activity of combination cancer treatments.
Explore NOXXON Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.